|
|
Article: Molecular Insight Pharmaceuticals' SAAC(TM) Technology Data Published in Bioconjugate Chemistry; Biotin Derivatives May Expand Applications of Radiolabeling Technologies.
- Article from:
- Business Wire
- Article date:
- May 31, 2006
CopyrightCOPYRIGHT 2006 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CAMBRIDGE, Mass. -- Molecular Insight Pharmaceuticals, Inc. announced today publication of two studies regarding the potential use of its Single Amino Acid Chelate (SAAC(TM)) technology for linking biotin and avidin to two common nuclear imaging and radiotherapeutic isotopes, technetium and rhenium. The studies, published in the current issue of Bioconjugate Chemistry, examine the potential utility of SAAC technology and create new avenues for developing targeted imaging agents and radiotherapeutics. E[acute accent]SAAC, Molecular Insight's unique metal-binding chemistry platform technology, incorporates a metal-binding (chelating) group into a single amino acid construct ...
Related newspaper, magazine, and journal articles:
|
|
Article: Molecular Insight Pharmaceuticals, Inc. To ...
Business Wire;
February 6, 2008 ;
700+ words
... ... CAMBRIDGE, Mass. -- Molecular Insight Pharmaceuticals, Inc. (NASDAQ ... Executive Officer of Molecular Insight Pharmaceuticals, Inc., will present ... Eastern Time Jade Room Molecular Insight Pharmaceuticals, Inc. Company ...
|
|